Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.1 EUR | -1.81% |
|
-11.04% | +67.07% |
05-30 | MPH Health Care AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-05 | M1 Kliniken Mull Uplisting to Frankfurt Bourse's Prime Standard; Co-CEOs Buy 1.5 Million Shares | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company has a low valuation given the cash flows generated by its activity.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- With an expected P/E ratio at 35.38 and 33.66 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+67.07% | 126M | - | - | |
+20.78% | 43.29B | B- | ||
+27.64% | 22.38B | B+ | ||
+19.25% | 15.51B | - | ||
+18.68% | 14.52B | B+ | ||
+54.64% | 12.93B | B | ||
-0.05% | 6.79B | - | - | |
-11.39% | 6.56B | B+ | ||
+18.33% | 5.87B | B+ | ||
-8.87% | 5.73B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 93M1 Stock
- Ratings MPH Health Care AG